Oslo universitetssykehus

Oslo 372

2 studies enrolling now · 12 studies all time

What they study most

Achondroplasia, Acute Myeloid Leukemia, Crohn's Disease, Duchenne Muscular Dystrophy, Low-grade Glioma, Medication Overuse Headache, Migraine, Neoplasms, Ovarian Cancer, Pediatric Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Rectal Cancer

Studies at this site

• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
• Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) — Recruiting now
• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial — Running, not enrolling
• Prospective Clinical Assessment Study in Children With Achondroplasia (ACH) — Completed
• A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache — Completed
• Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). — Completed
• A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) — Completed
• Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease — Completed
• A Study To Monitor Long-Term Treatment With PF-00547659 — Completed
• Extension Study of Drisapersen in DMD Subjects — NO_LONGER_AVAILABLE